Work

A Phase 2 Study of Axitinib (AG-013736), a Potential Inhibitor of VEGFRs, in Patients with Advanced Thyroid Cancer

Year: 2007

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2007.06.002

Authors: R. Cohen, E.E. Vokes, L. Rosen, M.S. Kies, F.P. Worden, M.A. Kane, A.A. Forastiere, K. Liau, P. Bycott, E.E.W. Cohen

Institutions: Fox Chase Cancer Center, University of Chicago, The University of Texas MD Anderson Cancer Center, U-M Rogel Cancer Center, Johns Hopkins University, Pfizer (United States)

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2010384685

FWCI:

Cites:

Cited by:

Related to: 10